InvestorsObserver
×
News Home

Where Does Iovance Biotherapeutics Inc (IOVA) Stock Fall in the Biotechnology Field After It Is Lower By -10.83% This Week?

Friday, March 15, 2024 12:38 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Iovance Biotherapeutics Inc (IOVA) Stock Fall in the Biotechnology Field After It Is Lower By -10.83% This Week?

Iovance Biotherapeutics Inc (IOVA) is near the top in its industry group according to InvestorsObserver. IOVA gets an overall rating of 79. That means it scores higher than 79 percent of stocks. Iovance Biotherapeutics Inc gets a 93 rank in the Biotechnology industry. Biotechnology is number 18 out of 148 industries.

Overall Score - 79
IOVA has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on IOVA!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 79 would rank higher than 79 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Iovance Biotherapeutics Inc Stock Today?

Iovance Biotherapeutics Inc (IOVA) stock is trading at $14.00 as of 12:27 PM on Friday, Mar 15, a drop of -$0.21, or -1.48% from the previous closing price of $14.21. The stock has traded between $13.68 and $14.39 so far today. Volume today is below average. So far 3,311,580 shares have traded compared to average volume of 13,117,590 shares. Click Here to get the full Stock Report for Iovance Biotherapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App